Evidence map›Paper›PMID 33902399›Full record

ArticleRedox report : communications in free radical research2021

Ascorbate-dependent and ascorbate-independent Mn porphyrin cytotoxicity: anticancer activity of Mn porphyrin-based SOD mimics through ascorbate-dependent and -independent routes.

Bader Hasan, Artak Tovmasyan, Ines Batinic-Haberle, Ludmil Benov

Open access · goldAbstract read
In one paragraph

Article in Redox report : communications in free radical research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Bader HasanDepartment of Biochemistry, Faculty of Medicine, Kuwait University, Kuwait City, Kuwait.
Artak TovmasyanDepartment of Neurobiology, Ivy Brain Tumor Center, Barrow Neurological Institute, Phoenix, AZ, USA.
Ines Batinic-HaberleDepartment of Radiation Oncology, Duke University School of Medicine, Durham, NC, USA.
Ludmil BenovDepartment of Biochemistry, Faculty of Medicine, Kuwait University, Kuwait City, Kuwait.ORCID https://orcid.org/0000-0002-0205-0146
Kuwait University · KWBarrow Neurological Institute · USDuke University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe aim of this study was to investigate how modifications at the periphery of the porphyrin ring affect the anticancer activity of Mn porphyrins (MnPs)-based SOD mimics.

methodsSix compounds: MnTE-2-PyP with a short ethyl chain on the pyridyl ring; MnTnHexOE-2-PyP and MnTnOct-2-PyP with linear 8-atom alkyl chains, but the former with an oxygen atom within the alkyl chain; MnTE-2-PyPhP and MnTPhE-2-PyP with pyridyl and phenyl substituents, were investigated. Cytotoxicity was studied using pII and MDA-MB-231 cancer cell lines. Viability was assessed by the MTT (3-[4,5-dimethylthiazol-2-yl)]-2,5-diphenyltetrazolium bromide) assay and cell proliferation was determined by the sulforhodamine B assay.

resultsCellular uptake was increased with the increase of the lipophilicity of the compounds, whereas reduction potential (

conclusionTwo different processes account for MnPs cytotoxicity. MnPs with appropriate

Indexed as

MetalloporphyrinsPorphyrinsAntioxidantsAscorbic AcidOxidation-ReductionSuperoxide DismutaseAntioxidantsAscorbic AcidMetalloporphyrinsPorphyrinsSuperoxide DismutaseAnticancer activityascorbatecellular uptakehydrogen peroxidemembrane damagemetalloporphyrinreactive oxygen speciestumoricidal

Identifiers

PMID33902399
PMCPMC8081310
OpenAlexW3158840989

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.